BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

SoluLinK, Inc. Announces Higher Binding Streptavidin Agarose


9/12/2011 9:32:10 AM

San Diego, California—June 14, 2011. Solulink, Inc., a leading innovator of state-of- the-art linking reagents, easy-to-use conjugation kits, and conjugation services for the life science research, diagnostics, and pharmaceutical markets, today announced it has launched a new higher binding streptavidin agarose, Streptavidin Agarose Ultra Performance™.

Solulink’s Streptavidin Agarose Ultra Performance™ was specifically developed with several key parameters in mind — high biotin binding capacity and low non-specific binding, on an agarose support which would support high flow rates with consistent permeation. These qualities make it an ideal media for applications such as immunoprecipitation (IP), co-immunoprecipitation (co-IP), chromatin immunoprecipitation (ChIP), affinity purification, cell capture, etc. Solulink utilizes a recombinant streptavidin which is of high purity, possessing much lower non-specific binding than avidin due to its lower isoelectric point and lack of glycosylation. This streptavidin is immobilized via Solulink’s proprietary linking technology, resulting in highly stable immobilizations with minimal protein leaching. Moreover, unlike other conjugation chemistries such as cyanogen bromide, Solulink’s conjugation process leaves the agarose with no net charge which could otherwise interact with biomolecules to cause unwanted binding. Our core agarose is specially formulated to be of unparalleled uniformity, with a relatively small mean diameter of 35µm. This, combined with its high level of crosslinking, creates a resin which is tolerant of high flow rates or centrifugal forces often experienced in high- throughput screening applications and immunoprecipitations.

Based on immunoprecipitation of ß-actin in a study, Solulink’s Streptavidin Agarose Ultra Performance™ captured at least 2 times more antigen than competing streptavidin agarose products under identical conditions. This increased binding capacity, along with its rigid core beaded agarose, makes it the ideal medium for capture of biotinylated biomolecules at all scales. The medium may be used either in batch format or packed into chromatography columns to suit the scale and process at hand.

About Solulink

Solulink’s proprietary conjugation reagents and easy-to-use linking kits provide unique features and benefits used to link proteins, oligonucleotides, peptides, and antibodies to each other or to a wide range of surfaces including beads, chips, and slides. Solulink markets its products both directly and through distributors and licensing partners worldwide. Solulink is a privately held company located in San Diego, California. For more information, please visit www.solulink.com.

Contact

Steve DeGraw

Solulink, Incorporated

9853 Pacific Heights Blvd. Suite H

San Diego, California 92121

T 858.625.0670

F 858.625.0770

sdegrawsolulink.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES